Asendin falls under the category of tricyclic antidepressants and is available only with a doctor’s prescription. The generic name used for Asendin is Amoxapine. It alters the neurotransmitter levels in the brain that helps in the process of promoting behavioural and emotional harmony in individuals suffering from depression. It mainly targets neurotransmitters like norepinephrine and serotonin which are responsible for energy and happiness. Teenagers and adults having thoughts and behaviour patterns associated to depression are treated using this medication. It helps in managing symptoms, but cannot completely cure it.
This medication is mainly used for the treatment of depression. With the help of this medication the significant low mood is uplifted and the sense of well-being is also significantly improved to experience everyday life in a positive way. The levels of the natural chemicals in the body are altered in order to restore its balance in the brain. Asendin has similar properties as of tranquilizers; therefore it is useful for people suffering from anxiety. Many anxiety disorders like panic disorder are treated using Asendin. Some doctors also prescribe Asendin for bipolar disorders.
There are quite some side-effects that can be seen in patients who have consumed Asendin. It is better to be aware of these side-effects. They are divided in two categories; major and minor. Some of these side-effects are as stated below:
Under certain medications Asendin is prohibited among patients. The doctor must make sure that the patient has none of the below mentioned conditions.
The doctor must be aware that the patient is pregnant or not. Any plans of pregnancy must be discussed with the doctor. Asendin has been assigned the pregnancy category C by the FDA. Hence, it should be prescribed only if the benefits are more than the potential risks.
Asendin is consumed orally in the form of tablets by patients.
Trade brand and generic names of Amoxapine: Amolife, Ascendin, Asendin, Asendis, Defanyl, Demolox, Moxadil, Oxamine.